study reporting no benefit regarding relapse rate Recommendation 8: (PICOs 10-11) The panel strongly recommends against the use of TNFa blocking agents for the treatment of PMR. The group agreed strongly against the use of TNFa blocking agents in PMR at this time since there is no evidence for benefit, but there is a considerable risk of potential harm and high resource use No recommendation can be made for other biologic agents as no prospective trials have been published so far. There is one